SARS-CoV-2-IN-59

SARS-CoV-2-IN-59

• CAS Number: 850786-33-3
• UNSPSC Description: SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189)[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-59.html
• Solubility: 10 mM in DMSO
• Smiles: N#CC1=CC=C(C2=NCCN2)C=C1
• Molecular Weight: 171.20
• References & Citations: [1]Azimi S, et al. Green and rapid and instrumental one-pot method for the synthesis of imidazolines having potential anti-SARS-CoV-2 main protease activity. Sustain Chem Pharm. 2023 Sep;34:101136.. .
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported